Octreotide Lar Injection About
Discover the phenomenal benefits of OCTRI-LAR Depot (Octreotide Lar Injection), meticulously crafted in India for the management of chronic conditions like acromegaly and neuroendocrine tumors. This celebrated, long-acting somatostatin analogue is administered via intramuscular injection, providing a superlative sustained release with reduced dosing frequency-just 30mg per vial. Each box contains a white to off-white powder and solvent for easy reconstitution. Fresh stock is available for export, supply, or trade-shop now to access reliable, prescription-based therapy for improved patient outcomes.
Strategic Application & Competitive Edge of Octreotide Lar Injection
OCTRI-LAR Depot is expertly indicated for use in patients with acromegaly, neuroendocrine tumors, and carcinoid tumors. Administered intramuscularly, its site-specific delivery ensures maximum efficacy. Competitive advantages include its reduced injection frequency, potent formulation for long-acting release, and celebrated clinical reliability. Superlative in its field, the preparation is favored by practitioners seeking consistent therapeutic results for chronic conditions requiring somatostatin analogues.
Certifications, Supply Chain Strength & Delivery Promise
OCTRI-LAR Depot boasts stringent certifications, attesting to its adherence to global pharmaceutical norms. Our robust supply ability ensures fresh packing & dispatch for orders of any scale, with delivery from a trusted FOB port in India. The asking price reflects our commitment to both quality and value. Each box is carefully packed and quickly delivered, supported by documentation and shelf-life guarantees for international clients.
FAQ's of Octreotide Lar Injection:
Q: How is Octreotide Lar Injection administered?
A: It is given as an intramuscular injection after reconstitution with the provided solvent. Administration should be handled by a healthcare professional as per physician guidelines.
Q: What are the primary uses of OCTRI-LAR Depot?
A: OCTRI-LAR Depot is recommended for adult patients managing chronic diseases such as acromegaly, neuroendocrine tumors, and carcinoid tumors requiring long-acting somatostatin analogue therapy.
Q: When should glucose and thyroid function be monitored with this injection?
A: Patients should have their glucose metabolism and thyroid function regularly monitored before and during treatment to ensure optimal therapy outcomes.
Q: Where should Octreotide Lar Injection be stored?
A: Store the injection below 25C, protected from light, and always refer to the manufacturer's expiry date for optimal safety and efficacy.
Q: What does each box of Octreotide Lar Injection contain?
A: Each box contains one vial of white to off-white powder and one vial of solvent for reconstitution, providing a single 30mg dose for intramuscular suspension.
Q: Is a prescription required to purchase Octreotide Lar Injection?
A: Yes, this is a Schedule H medicine in India and must be sold only on the prescription of a registered medical practitioner.